TABLE 3.
Adjusted ORs for comorbidities associated with the presence of CRS in patients with bronchiectasis
| OR (95% CI) | p value | N | |
|---|---|---|---|
| Asthma | |||
| Unadjusted | 1.58 (1.19–2.11) | <0.01 | 900 |
| Adjusted for age, sex, race | 1.56 (1.17–2.10) | <0.01 | 900 |
| GERD | |||
| Unadjusted | 1.51 (1.15–1.97) | <0.01 | 900 |
| Adjusted for age, sex, race | 1.56 (1.19–2.05) | <0.01 | 900 |
| Allergic rhinitis | |||
| Unadjusted | 2.05 (1.45–2.91) | <0.01 | 900 |
| Adjusted for age, sex, race | 1.99 (1.41–2.83) | <0.01 | 900 |
| Antibody deficiency | |||
| Unadjusted | 2.04 (1.32–3.17) | <0.01 | 900 |
| Adjusted for age, sex, race | 1.83 (1.18–2.88) | 0.01 | 900 |
| COPD | |||
| Unadjusted | 1.34 (0.99–1.83) | 0.06 | 900 |
| Adjusted for age, sex, race | 1.37 (1.01, 1.88) | 0.05 | 900 |
| Autoimmune disease | |||
| Unadjusted | 0.92 (0.63–1.33) | 0.65 | 900 |
| Adjusted for age, sex, race | 0.90 (0.61–1.33) | 0.60 | 900 |
CI = confidence interval; CRS = chronic rhinosinusitus; COPD = chronic obstructive pulmonary disease; GERD = gastroesophageal reflux disease; OR = odds ratio.